Transcriptional Repressor HIC1 Contributes to Suppressive Function of Human Induced Regulatory T Cells
Autor: | Urvashi Bhatia, Catharina C. Gross, Harri Lähdesmäki, Kanchan Bala, Deepankar Chakroborty, Syed Bilal Ahmad Andrabi, Subhash K. Tripathi, Kartiek Kanduri, Johanna Tuomisto, Sari Lehtimäki, Heinz Wiendl, Sini Rautio, Omid Rasool, Obaiah Dirasantha, Ullah Ubaid Ullah, Laura L. Elo, Riitta Lahesmaa |
---|---|
Přispěvatelé: | Åbo Akademi University, Department of Computer Science, Professorship Lähdesmäki Harri, University of Münster, Aalto-yliopisto, Aalto University |
Jazyk: | angličtina |
Rok vydání: | 2018 |
Předmět: |
0301 basic medicine
Transcription Genetic FOXP3 Cell Kruppel-Like Transcription Factors T cells Polymorphism Single Nucleotide T-Lymphocytes Regulatory Article General Biochemistry Genetics and Molecular Biology Autoimmune Diseases 03 medical and health sciences 0302 clinical medicine Immune system Downregulation and upregulation Transcriptional regulation medicine Humans Cell Lineage transcriptional regulation ta318 regulatory SNP Transcription factor lcsh:QH301-705.5 iTreg ta113 expression kinetics Binding Sites Genome Human Sequence Analysis RNA Effector Cell growth Gene Expression Profiling Cell Differentiation DNA HIC1 suppression 3. Good health Cell biology Repressor Proteins ChIP-seq 030104 developmental biology medicine.anatomical_structure lcsh:Biology (General) RNA-seq Transcriptome 030217 neurology & neurosurgery Protein Binding |
Zdroj: | Cell Reports, Vol 22, Iss 8, Pp 2094-2106 (2018) Cell Reports |
ISSN: | 2211-1247 |
Popis: | Summary Regulatory T (Treg) cells are critical in regulating the immune response. In vitro induced Treg (iTreg) cells have significant potential in clinical medicine. However, applying iTreg cells as therapeutics is complicated by the poor stability of human iTreg cells and their variable suppressive activity. Therefore, it is important to understand the molecular mechanisms of human iTreg cell specification. We identified hypermethylated in cancer 1 (HIC1) as a transcription factor upregulated early during the differentiation of human iTreg cells. Although FOXP3 expression was unaffected, HIC1 deficiency led to a considerable loss of suppression by iTreg cells with a concomitant increase in the expression of effector T cell associated genes. SNPs linked to several immune-mediated disorders were enriched around HIC1 binding sites, and in vitro binding assays indicated that these SNPs may alter the binding of HIC1. Our results suggest that HIC1 is an important contributor to iTreg cell development and function. Graphical Abstract Highlights • Hypermethylated in cancer 1 (HIC1) is upregulated in iTreg cells • HIC1-deficient iTreg cells express FOXP3 but have reduced suppressive ability • Autoimmune-disease-associated SNPs are enriched within HIC1 binding loci • HIC1 is an important regulator of iTreg development and function Ullah et al. find that HIC1 is induced during human iTreg cell differentiation. HIC1 binds to and regulates the expression of key genes during iTreg differentiation. Several autoimmune-disease-associated SNPs are enriched near HIC1 ChIP-seq peaks. |
Databáze: | OpenAIRE |
Externí odkaz: |